Bruker Announces Resignation of Chief Financial Officer and Appointment of Interim Chief Financial Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Jefferies Remains Bullish in the Wake of Bruker's (BRKR) Surprise CFO Departure
May 21, 2015 7:50 AM EDTJefferies maintains a Buy rating and $25 price target on Bruker (NASDAQ: BRKR) following the surprise departure of CFO, Charlie Wagner. It was announced last night that Wagner will be stepping down as CFO next month to join Ortho-Clinical Diagnostics (OCD) as CFO. Analyst Brandon Couillard believes that the departure will have a negative psychological impact... More
William Blair Downgrades Bruker (BRKR) to Market Perform
May 21, 2015 6:43 AM EDTWilliam Blair downgraded Bruker (NASDAQ: BRKR) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.
Shares of Bruker closed at $22.21 yesterday.
... MoreBruker (BRKR) CFO Wagner to Resign
May 20, 2015 4:10 PM EDTBruker Corporation (NASDAQ: BRKR) announced that on May 19, 2015, Mr. Charles F. Wagner, Jr., Executive Vice President and the Chief Financial Officer (CFO) of Bruker since July 2012, submitted his resignation, effective June 12, 2015, in order to pursue other interests. Mr. Wagner has informed the Company that he has accepted a position as Chief Financial Officer of Ortho-Clinical Diagnostics, Inc., and will commence service in that position in late June 2015. Mr. Wagners resignation is not the result of any dispute or disagreement with the Company or any matter relating to the Companys accounting practices or financial... More
